Starlix (nateglinide) is a small molecule pharmaceutical. Nateglinide was first approved as Starlix on 2000-12-22. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
|Indication||type 2 diabetes mellitus|
|Drug Class||Antidiabetic, SGLT2 inhibitors, not phlorozin derivatives|